Stimulus-induced uncoupling of extracellular signal-regulated kinase phosphorylation from nuclear localization is dependent on docking domain interactions by Caunt, Christopher J & McArdle, C A
        
Citation for published version:
Caunt, CJ & McArdle, CA 2010, 'Stimulus-induced uncoupling of extracellular signal-regulated kinase
phosphorylation from nuclear localization is dependent on docking domain interactions', Journal of Cell Science,
vol. 123, no. 24, pp. 4310-4320. https://doi.org/10.1242/jcs.076349
DOI:
10.1242/jcs.076349
Publication date:
2010
Link to publication
The final published article is available from http://jcs.biologists.org
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 12. May. 2019
Stimulus-induced uncoupling of extracellular signal-regulated kinase phosphorylation 
from nuclear localization is dependent on docking domain interactions 
Christopher J. Caunt1 and Craig A. McArdle2 
1Dept. of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, 
UK. 2Laboratories for Integrative Neuroscience and Endocrinology, Dept. of Clinical 
Sciences at South Bristol, University of Bristol, Whitson Street, Bristol, BS1 3NY, UK. 
Abstract 
Many stimuli activate the extracellular signal regulated kinase (ERK) by phosphorylation on 
the TEY motif. Activated ERK characteristically accumulates in the nucleus, but mechanisms 
involved are unclear. Using automated microscopy to explore ERK regulation in single intact 
cells, we find that when protein kinase C or epidermal growth factor receptors are activated, a 
substantial fraction of the ERK nuclear localization response is uncoupled from TEY 
phosphorylation. This phosphorylation unattributable nuclear localization response occurs in 
the presence of tyrosine phosphatase and protein synthesis inhibitors. It was also seen with a 
catalytically inactive ERK2-GFP mutant, and with a mutant incapable of binding the DEF 
(docking site for ERK, F/Y-X-F/Y-P) domains found in many ERK binding partners. It was, 
however, reduced by MEK inhibition and by mutations preventing either TEY 
phosphorylation or D (docking)-domain dependent ERK binding (D319N). Thus, we show 
that MEK catalysed ERK phosphorylation is necessary but not sufficient for the full nuclear 
localization response: there is an additional phosphorylation unattributable component of the 
response that does not reflect induced expression of nuclear anchors and is independent of 
ERK catalytic activity or DEF-domain binding. It is, however, dependent upon D-domain 
binding, highlighting distinct roles of ERK motifs during nuclear targeting. 
Keywords: 
ERK, MAPK, protein kinase C, epidermal growth factor, docking domain, nuclear 
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Introduction 
A wide variety of extracellular signals activate the 
Raf-MEK-ERK pathway. In this cascade, Raf 
isoforms are recruited to the cell membrane for 
activation, which phosphorylate and activate MEK 
(MAPK/ERK kinase). Activated MEK in turn 
phosphorylates ERK1 and 2 (referred to as ERK 
herein) on Thr and Tyr residues of a TEY activation 
loop (Caunt et al., 2006a; Raman et al., 2007). ERK 
is chiefly cytoplasmic in resting cells, but activation 
causes its accumulation in the nucleus (Chen et al., 
1992; Lenormand et al., 1993; Lidke et al., 2010). 
This is crucial for ERK to access transcriptional 
targets, and correct localization is essential for the 
integrity of cell fate decisions, such as proliferation 
and differentiation (Brunet et al., 1999; Robinson et 
al., 1998). ERK does not contain intrinsic nuclear 
localization or export signals, and relies on dynamic 
association with a wide repertoire of proteins for 
appropriate subcellular targeting (von Kriegsheim et 
al., 2009). The distribution of ERK between the 
nucleus and the cytoplasm is dependent upon rates 
of nuclear entry and exit (Costa et al. 2006; Lidke et 
al. 2010). ERK can enter and exit the nucleus via an 
energy-independent process that is facilitated by 
direct interaction with nuclear pore proteins and 
TEY phosphorylated ERK can also be imported by a 
second process requiring both energy and cytosolic 
factors (Ranganathan et al. 2006; Yazicioglu et al. 
2007; Whitehurst et al. 2002). Cytoplasmic and 
nuclear binding proteins can also influence ERK 
distribution by affecting the fraction of ERK 
available for movement to or from the nucleus. 
MEK is a major cytoplasmic scaffold of ERK and 
MEK-directed ERK phosphorylation of the TEY 
motif causes its liberation from MEK, facilitating its 
interaction with other proteins including those of the 
nuclear pore complex. In this way, MEK activation 
characteristically increases the nuclear localisation 
of ERK, an effect that is dependent upon the TEY 
motif (Adachi et al., 1999; Chuderland et al., 2008b; 
Fukuda et al., 1997; Lenormand et al., 1998; Wolf et 
al., 2001) but not on ERK catalytic activity (Adachi 
et al., 1999; Gonzalez et al., 1993; Khokhlatchev et 
al., 1998; Yazicioglu et al., 2007). Other proteins 
that that can cause cytoplasmic retention of ERK 
include PEA-15, dual specificity phosphatase 
(DUSP) 6, β-arrestin and Sef (Brunet et al., 1999; 
Caunt et al., 2006b; Formstecher et al. 2001; 
Karlsson et al., 2004; Luttrell et al., 2001; Tohgo et 
al., 2002; Torii et al., 2004). In contrast, expression 
of nuclear DUSPs 2, 4 and 5 can mediate 
dephosphorylation and nuclear anchoring of ERK in 
sustained phases of signaling (Caunt et al., 2008a; 
Caunt et al., 2008b; Mandl et al., 2005; Volmat et 
al., 2001). Thus, many proteins influence ERK 
compartmentalization, and correct interpretation of 
these often conflicting signals is essential during 
dynamic changes in localization. 
The specificity of the association of ERK with its 
binding proteins is dictated by docking domains. 
The ERK common docking (CD) motif is distal to 
the catalytic site and binds to Lys and Arg-rich 
sequences, known as D (docking)-domains (Tanoue 
et al., 2001). Another key docking site in ERK 
protein partners is termed the DEF (docking site for 
ERK, F/Y-X-F/Y-P) motif, which binds to a DEF-
binding pocket (DBP) adjacent to the catalytic site 
of ERK (Jacobs et al., 1999; Lee et al., 2004). ERK 
protein partners can contain either or both D- and 
DEF-domains allowing intricate regulation of ERK 
recognition (Dimitri et al., 2005; Jacobs et al., 1999; 
Shin et al., 2010). The MEK-ERK interaction is 
multivalent, involving both the CD motif and the 
DBP of ERK (Robinson et al., 2002). 
Phosphorylation and release of ERK from MEK 
therefore exposes these docking sites during 
stimulus-mediated responses. Recent studies have 
shown that D319N and Y261A mutations can 
interfere with ERK binding to partner D- or DEF-
domain containing proteins, respectively, in intact 
cells without affecting phosphorylation or overall 
catalytic activation by MEK (Caunt et al., 2008a; 
Caunt et al., 2008b; Dimitri et al., 2005; Shin et al., 
2010). These mutations can therefore be used to 
identify ERK responses that are dependent on D- or 
DEF-domain interactions. 
Uncoupling of ERK phosphorylation and nuclear 
localization responses occurs in a number of models, 
but the mechanisms remain largely unknown. Most 
previous work exploring relationships between ERK 
phosphorylation and compartmentalization in 
attached cells has involved biochemical assays with 
cell homogenates or microscopy with relatively 
small cell numbers. Here, we have taken a novel 
approach, using automated fluorescence microscopy 
and image analysis to monitor ppERK1/2 levels and 
the nuclear:cytoplasmic (N:C) ERK1/2 ratio in large 
numbers of single attached cells. This enables 
response characteristics to be defined from 
frequency distributions and in cell sub-populations 
selected (i.e. binned) according to ppERK1/2 level. 
Using population averaged data we found that 
protein kinase C (PKC) activation using phorbol 12, 
13 dibutyrate (PDBu) and epidermal growth factor 
(EGF) caused the expected dose- and time­
dependent increases in ppERK1/2 and ERK1/2 N:C. 
However, with data binned according to ppERK1/2 
levels, both activators still caused a pronounced 
increase in ERK1/2 N:C. This reveals a clear 
component of the endogenous ERK nuclear 
localization response that cannot be attributed to 
TEY phosphorylation of ERK. Exploring 
mechanisms (with chemical inhibitors and a system 
in which endogenous ERK is replaced with wild-
type or mutated ERK2-GFP) revealed that this 
component of the response was dependent on MEK 
activity and TEY phosphorylation of ERK. It was 
also dependent upon D-domain dependent binding 
but not on DEF-domain dependent binding, protein 
neosynthesis or ERK catalytic activity. Thus, we 
have found that MEK-directed TEY phosphorylation 
of ERK is necessary but not sufficient for the full 
PDBu- and EGF-stimulated nuclear localization 
response. There is an additional TEY 
phosphorylation unattributable component of the 
response that is dependent upon D-domain mediated 
binding of ERK to, as yet, unidentified partners. 
Results 
Using high-content microscopy to study ERK 
phosphorylation and localization 
We examined spatial and temporal aspects of ERK 
regulation by immunofluorescence microscopy. 
Total ERK1/2 and ppERK1/2 were stained 
simultaneously and quantified using a high-content 
image platform for automated image acquisition and 
analysis. Stimulation of conventional and atypical 
PKC isoforms with PDBu caused dose and time-
dependent increases in whole cell levels of dual 
phosphorylated ERK (ppERK1/2), providing a 
measure for ERK activation. It also caused dose- and 
time-dependent increases in the nuclear:cytoplasmic 
(N:C) ERK1/2 ratio, providing a measure for nuclear 
localization. The kinetics of these two responses 
differed (Fig. 1). The effect of PDBu on ppERK1/2 
levels was maximal at 5 minutes and then decreased 
to a plateau level (10-30% of maximal) that was 
maintained from 60 minutes to 6 hours. This is 
consistent with earlier data (Caunt et al., 2008a; 
Caunt et al., 2008b) and with response kinetics 
obtained by Western blotting for ppERK1/2 in 
whole cell lysates (Fig. 1). Western blotting revealed 
sustained MEK phosphorylation from 5-240 minutes 
so the reduction in ppERK1/2 levels occurred in 
spite of ongoing MEK activation over this period. 
The ERK nuclear localization response also 
increased to a peak at 5 minutes then reduced briefly 
before increasing again to a maximum at 2 hours (1 
μM PDBu) or 6 hours (0.1 μM PDBu). This 
uncoupling of the relatively transient effect of PDBu 
on ppERK1/2 from its more sustained effect on 
ERK1/2 N:C has previously been attributed to 
nuclear DUSPs that can both dephosphorylate and 
anchor ERK in the nucleus (Caunt et al., 2008a; 
Caunt et al., 2008b; Mandl et al., 2005; Volmat et 
al., 2001). Consistent with this, we found that PDBu 
also caused a pronounced increase in whole cell 
levels of DUSP1 (the prototypic nuclear DUSP) at 
1–4 hours after stimulation (Fig. 1). 
Analysis of cell sub-populations reveals uncoupling 
of ERK phosphorylation from nuclear localization. 
The data described above were derived from 
population averages (thousands of imaged or lysed 
cells) but the microscopy methods used also provide 
data on each individual cell. This is particularly 
important for ERK signaling because at the single 
cell level stimuli cause digital “all-or-nothing” 
responses in some models and graded responses in 
others (Ferrell and Machleder, 1998; Lin et al., 
2009; Mackeigan et al., 2005; Whitehurst et al., 
2004). Moreover, a recent study found that graded 
ERK phosphorylation causes digital increases in 
immediate early gene expression, raising the 
question of whether ERK translocation to the 
nucleus is digital or graded (Mackeigan et al., 2005). 
To assess this, we generated frequency distribution 
histograms for whole cell ppERK1/2 levels and 
ERK1/2 N:C ratios in control and PDBu stimulated 
cells (Fig. 2A). As expected, stimulation for 5 
minutes with 1 μM PDBu shifted the frequency-
response plots rightward, yielding near-normal 
distribution curves for both measures with 
ppERK1/2 and ERK1/2 N:C mode values increased 
approx. 8 and 2-fold above controls (respectively). 
The histograms obtained with 0.1 μM PDBu were 
also near normally distributed with intermediate 
mode values (6 and 1.6 fold above control for 
ppERK1/2 and ERK1/2 N:C, respectively). This is 
in sharp contrast to the bimodal distribution seen 
with digital responses (Lin et al., 2009), revealing 
that ERK1/2 phosphorylation and nuclear 
localization are both graded responses in HeLa cells. 
Similar data were seen in MCF7 cells (not shown). 
A further feature of these plots is that whole cell 
ppERK1/2 values were broadly spread (99% of cells 
within a 30-fold range of ppERK1/2 levels) as 
compared to the much tighter N:C ERK1/2 range 
(99% of cells within 3-fold N:C ERK1/2 range) (Fig. 
2A). This suggests uncoupling of the responses, with 
relatively constant nuclear localization over a broad 
range of ppERK1/2 levels. To test for this, we sorted 
the cells into bins according to ppERK1/2 level 
(each spanning 80 arbitrary fluorescence units 
(AFU)) and for each bin, plotted the mean 
ppERK1/2 value against the mean ERK1/2 N:C ratio 
in the same cells. In control cells this revealed a 
positive correlation between the ppERK1/2 and N:C 
ERK1/2 measures (Fig. 2B). In contrast, when cells 
were treated for 2 hours with 1 μM PDBu an entirely 
different relationship was observed with the N:C 
ERK1/2 ratio decreasing with increased ppERK1/2 
levels but remaining greater than that of control cells 
in all ppERK1/2 bins (Fig.2B). This uncoupling of 
the two responses most likely reflects the ability of 
PDBu to increase expression of nuclear DUSPs that 
dephosphorylate and scaffold ERK in the nucleus 
(Caunt et al., 2008a; Caunt et al., 2008b; Mandl et 
al., 2005; Volmat et al., 2001). Surprisingly 
however, 5 minutes stimulation with PDBu also 
caused a substantial increase in ERK1/2 N:C ratio 
over a wide range of ppERK1/2 bins in spite of the 
fact that this is insufficient time for increased DUSP 
expression (Fig. 2B). Similar data were obtained in 
MCF7 cells and in primary mouse embryonal 
fibroblast cultures. In all three cell types data 
binning revealed a pronounced uncoupling of the 
ppERK1/2 response from the ERK1/2 N:C response 
after 2 hours of stimulation with 1 μM PDBu, and a 
less pronounced but statistically significant 
uncoupling at 5 minutes (Fig. 2 and Supplemental 
Fig. 2). 
The data outlined above demonstrate that the effects 
of PDBu on ERK nuclear distribution cannot solely 
be attributed to TEY phosphorylation, because 
PDBu causes pronounced increases in ERK1/2 N:C 
in the absence of any measurable increase in 
ppERK1/2 (i.e. using bins with matched and 
indistinguishable ppERK1/2 levels). They also 
reveal that analysis of the subset of cells within a 
relatively narrow ppERK1/2 range provides a simple 
means of quantifying this component in isolation. 
We next stimulated cells for 5 minutes with varied 
concentrations of PDBu and compared population 
average responses with those in cell subsets matched 
for ppERK1/2 levels. With population averaged 
data, PDBu caused the expected concentration-
dependent increases in ppERK1/2 and N:C ERK1/2 
ratio with comparable potency for both effects (log 
EC50 values -6.9±0.2 and -7.2±0.2 respectively, Fig. 
3). When similar plots were generated only for cells 
within a narrow range of ppERK1/2 levels (240-280 
AFU), PDBu caused no measurable increase in 
ppERK1/2 but did cause a concentration-dependent 
increase in N:C ERK1/2 ratio. These data reveal that 
PDBu-mediated nuclear localization of ERK1/2 is 
proportional to stimulus, even under conditions 
where it is not proportional to ppERK1/2 level. 
Thus, we show for the first time the extent to which 
mechanisms other than phosphorylation-dependent 
release from MEK are employed to achieve the full 
ERK nuclear localization response elicited by PKC 
activation. 
We also determined the time-course of PDBu action 
by stimulating cells with 1 μM PDBu for 5 minutes - 
6 hours and generated single cell frequency 
distribution plots (for ppERK1/2 and ERK1/2 N:C) 
and found as expected, that the mode values for 
ppERK1/2 and ERK1/2 N:C paralleled the 
population average responses (Supplemental Fig.1 
and Fig. 4A). We also binned the data according to 
ppERK1/2 level and plotted this against ERK1/2 
N:C (as above) and this revealed clear uncoupling of 
the responses at all time points (Supplemental Fig. 
1). This can readily be visualized by plotting the 
time-course of the PDBu effect using only cells 
within a single relatively low ppERK1/2 bin (240­
320 AFU). As shown (Fig. 4) PDBu caused a 
pronounced increase in N:C ERK1/2 ratio in this 
sub-population in spite of the fact that it caused no 
measurable increase in ppERK1/2. The time-courses 
of effects on ERK1/2 distribution were very similar 
in the binned and population averaged responses 
although the transient increase in ppERK1/2 levels 
was clearly seen in the population average data 
(compare Fig. 4A and 4B). 
We next used the same approach to explore 
stimulus-specificity. Population averaged data 
revealed that epidermal growth factor (EGF) causes 
a transient increase in ppERK1/2 and also increases 
the N:C ERK1/2 ratio. As in earlier work (Caunt et 
al., 2008a; Caunt et al., 2008b; Whitehurst et al., 
2004) the magnitude and kinetics of the EGF effect 
on ppERK1/2 levels were similar to those seen with 
PDBu, but EGF was less effective than PDBu at 
driving ERK1/2 nuclear localization (Fig. 5A). The 
tyrosine phosphatase inhibitor sodium orthovanadate 
(vanadate) caused a slow and near linear increase in 
ppERK1/2 (without any increase in N:C ERK1/2 
ratio) demonstrating involvement of tyrosine 
phosphatases in basal ppERK1/2 turnover (Fig. 5A). 
We also binned the single cell data according to 
ppERK1/2 level in order to compare effects of these 
stimuli under conditions with comparable average 
ppERK1/2 levels (5 minutes stimulation for PDBu 
and EGF, and 6 hours for vanadate). This revealed 
the expected positive correlation between ppERK1/2 
levels and N:C ERK1/2 ratio in control cells and 
clear uncoupling of the responses, with PDBu 
increasing N:C ERK1/2 as compared to control cells 
matched for ppERK1/2. Similar uncoupling was 
seen in EGF-stimulated cells, but not in response to 
vanadate, where only a modest elevation in ERK1/2 
N:C occurred, even at very high ppERK1/2 levels 
(Fig. 5B). These data echo earlier results showing 
that ERK nuclear accumulation is dictated by 
stimulus type (Whitehurst et al., 2004), and support 
the idea that stimulus-induced and basal trafficking 
of ERK operate via distinct mechanisms (Casar et 
al., 2007). 
PDBu-induced uncoupling of ERK phosphorylation 
from nuclear localization is dependent on MEK. 
We next used a range of pharmacological inhibitors 
to explore possible mechanisms underlying ERK 
activation and nuclear localization. Using maximally 
effective inhibitor concentrations established in 
control assays (not shown), we treated HeLa cells 
for 10 minutes prior to acute (5 minute) stimulation 
with PDBu. Population averaged data revealed that 
the effects of PDBu on ppERK1/2 and N:C ERK1/2 
ratio were dependent upon PKC and MEK (inhibited 
by Ro31-8425 and PD184352) and independent of 
Src (uninfluenced by SU6656). The responses were 
also unaltered by vanadate or cycloheximide (CHX), 
demonstrating that tyrosine phosphatases and protein 
neosynthesis do not influence these acute responses 
(although they do alter responses to long-term PDBu 
stimulation in this model; unpublished data and 
(Caunt et al., 2008a; Caunt et al., 2008b)). Focusing 
on cell sub-sets with a narrow range of ppERK1/2 
levels (240-320 AFU) again revealed a dose-
dependent effect of PDBu on ERK1/2 N:C (Fig. 
6B). This nuclear localization response was 
completely blocked by Ro31-8425 and PD184352, 
demonstrating dependence on PKC and MEK, 
respectively. However, it was uninfluenced by 
SU6656, vanadate and CHX, demonstrating 
independence from Src, tyrosine phosphatase 
activity and protein neosynthesis. These effects were 
seen under conditions matched for low ppERK1/2 
levels and in which ppERK1/2 was not measurably 
altered by the stimulus or the inhibitors (Fig. 6B, 
lower right panel). Thus the component of the acute 
PDBu-induced translocation response that cannot be 
solely attributed to TEY phosphorylation of ERK1/2 
is nevertheless dependent on MEK activation. This 
may explain why this component is seen with 
stimuli that activate MEK (PDBu and EGF) but not 
with a treatment that increases ppERK1/2 by 
phosphatase inhibition (vanadate) (Fig. 5B). 
PDBu-induced uncoupling of ERK phosphorylation 
from translocation is dependent on D-domains. 
To further explore relationships between ERK 
phosphorylation and localization we used a 
previously characterised system in which siRNAs 
are used to reduce expression of endogenous ERK, 
and recombinant adenoviruses (Ad) are used to 
introduce GFP-tagged wild-type (WT) or mutated 
ERK2 reporters. As shown (Fig. 7A) the siRNAs 
reduced endogenous ERK levels by >95%. This was 
paralleled by reduced PDBu-stimulated ERK 
phosphorylation (as measured by cell imaging or by 
Western blotting) and Egr-1 Luc activity (early 
growth response-1 promoter-luciferase reporter, 
used as a transcriptional readout for ERK 
activation). Addition of Ad ERK2-GFP restored 
ERK2 expression levels, as well as PDBu-stimulated 
ERK2 phosphorylation and Egr-1 Luc responses to 
wild-type levels (Fig. 7A, data not shown and 
(Caunt et al., 2008a; Caunt et al., 2008b)). A similar 
approach was used to add-back mutated ERK2-GFP 
constructs (after siRNA knock-down) and Western 
blotting revealed comparable expression levels for 
WT ERK2-GFP and for reporters containing K52R 
(catalytically inactive), T183/Y185A (non-TEY 
phosphorylatable), Y261A (deficient in binding DEF 
domains) and D319N (deficient in binding D-
domains) variants of ERK2-GFP. None of the 
mutations inhibited MEK expression or PDBu­
stimulated MEK phosphorylation (Fig. 7A). 
Imaging assays (population averaged data) were 
then used to define effects of these mutations on 
responses to PDBu. As shown (Fig. 7B), 5 minutes 
stimulation with PDBu caused a dose-dependent 
increase in ERK2-GFP phosphorylation (whole cell 
ppERK2) and nuclear localization (ERK2-GFP 
N:C), and 6 hours stimulation caused a 
corresponding increase in Egr-1 Luc activity. All 3 
responses were markedly reduced in cells expressing 
the non-TEY phosphorylatable T183/Y185A ERK2­
GFP mutant, confirming the effectiveness of the 
mutation as well as the dependence of nuclear 
localization and nuclear signaling on TEY 
phosphorylation. PDBu also dose-dependently 
increased phosphorylation and nuclear localization 
of the K52R mutant, but the Egr-1 response was 
greatly reduced, demonstrating that activation of the 
transcription reporter requires ERK catalytic activity 
whereas the phosphorylation and nuclear 
localization responses do not (Gonzalez et al., 1993). 
Interestingly, the basal ppERK2 levels and ERK2­
GFP N:C ratio were increased with this mutant (Fig. 
7B), which may well reflect a lack of negative 
feedback requiring ERK catalytic activity 
(Catalanotti et al., 2009; Dougherty et al., 2005). 
The Y261A mutation, which inhibits DEF domain-
dependent binding, did not affect ERK2-GFP 
phosphorylation in response to PDBu but did 
increase N:C ERK2-GFP ratios in basal and 
stimulated cells, and actually reduced PDBu­
stimulated Egr-1 Luc activity (Fig. 7B). The latter 
effect is known to reflect dependence on DEF-
directed phosphorylation and activation of 
immediate early gene transcription factors (Dimitri 
et al., 2005; Murphy et al., 2004; Murphy et al., 
2002). In contrast, inhibition of ERK2 binding to D-
domain partners (D319N mutation) did not affect 
ERK2-GFP phosphorylation, but substantially 
reduced nuclear localization and doubled Egr-1 Luc 
responses (Fig. 6B). Together, these findings show 
that each of these biochemical motifs is necessary 
for correct regulation of ERK1/2 localization and 
downstream response, and confirm that effects of 
catalysis and docking interactions can be 
functionally separated in vivo using this system. 
We next asked whether the uncoupling of ERK 
phosphorylation from nuclear localization seen with 
endogenous ERK would also be seen with the 
knock-down/add-back model. To do so, cells 
expressing endogenous ERK were stimulated for 5 
minutes with 0, 0.1 or 1 μM PDBu before staining 
for ppERK1/2 and ERK1/2. Cells transduced with 
ERK2-GFP were treated similarly (except that the 
GFP fluorescence was used instead of total ERK1/2 
staining) and the single cell data was binned 
according to ppERK1/2 level. In control cells 
expressing endogenous ERK the expected positive 
correlation between ppERK1/2 and ERK1/2 N:C, as 
was the marked uncoupling of responses (i.e. the 
PDBu-induced increase in ERK1/2 N:C in cell 
subsets with matched ppERK1/2 level). Very similar 
data were obtained in cells transduced with ERK2­
GFP (Fig. 8). 
The previous data show that the GFP tag does not 
interfere with the component of the nuclear 
localization response that cannot be attributed to 
TEY phosphorylation, and provided the opportunity 
to explore mechanisms using the ERK2-GFP 
mutants. Accordingly, we compared the effect of the 
ERK2-GFP mutants on stimulus-dependent 
localization within matched ppERK2 levels. This 
analysis clearly cannot be performed with the 
T183/Y185A mutant (which lacks the TEY 
phosphorylation epitope). As expected, there was 
clear uncoupling of nuclear localization from 
phosphorylation in cells expressing WT ERK2-GFP 
and stimulated for 5 min with 0.1 or 1 μM PDBu. 
Very similar data were obtained in cells expressing 
the K52R and Y261A mutants (Fig. 9A). In contrast, 
the uncoupling of phosphorylation from nuclear 
localization was much less pronounced in cells 
expressing D319N ERK2-GFP (Fig. 9A). This 
distinction was also evident in dose-response studies 
where data are plotted for the sub-set of cells within 
a single narrow ppERK2 bin (160-240 AFU). This 
revealed a clear dose-dependent increase in N:C 
ERK2-GFP under conditions where there was no 
measurable PDBu-stimulated increase in ppERK2 
(Fig. 9B). The nuclear localization response seen 
with the binned data was greatly reduced in cells 
expressing D319N ERK2-GFP. Consistent with the 
population averaged data (Fig. 7) we also found that 
the K52R and Y261A mutants increased ERK2-GFP 
N:C ratios in the absence of stimulus and this was 
additive with the PDBu effects. Together, these data 
demonstrate that there is an additional component of 
the nuclear localization response that cannot be 
attributed to TEY phosphorylation, does not require 
catalysis or DEF domain-dependent binding, but is 
largely prevented by the D319N mutation and 
therefore requires D-domain-dependent binding. 
Discussion 
The compartmentalization of ERK dictates substrate 
access and in turn controls cell fate decisions. ERK 
does not contain nuclear localization or export 
sequences, so its compartmentalization is 
determined largely by binding to scaffolds, anchors 
and substrates (Caunt et al., 2006a). In unstimulated 
cells ERK is mainly bound to MEK in the cytoplasm 
(Chuderland et al., 2008b; Fukuda et al., 1997). 
When MEK catalyses the TEY phosphorylation of 
ERK, this not only activates the enzyme but also 
causes its dissociation from MEK and exposes 
binding motifs enabling its interaction with other 
binding partners including components of the 
nuclear transport pore (Adachi et al., 1999; Lee et al. 
2004; Wolf et al., 2001; Yazicioglu et al. 2007). The 
importance of MEK for cytoplasmic retention of 
ERK in unstimulated cells is illustrated by the 
characteristic redistribution of ERK from the 
cytoplasm to the nucleus seen when MEK is 
activated (Adachi et al., 1999; Chen et al., 1992; 
Lenormand et al., 1993). TEY phosphorylation of 
ERK may be insufficient for maximal stimulation of 
nuclear ERK localization as additional 
phosphorylation sites (Ser 244, Ser 246 and Thr 188) 
are also implicated in control of nuclear localization 
(Chuderland et al. 2008a; Lorenz et al. 2009). 
Moreover, ERK can be largely restricted to the 
cytoplasm by elevation of the cytoplasmic Ca2+ 
concentration which can inhibit its transport into the 
nucleus (Chuderland et al., 2008b) and by engaging 
signaling pathways in which β-arrestin binding 
retains ERK in the cytoplasm (Caunt et al., 2006b; 
Luttrell et al., 2001; Tohgo et al., 2002). 
Conversely, many activators of ERK also increase 
expression of nuclear-inducible DUSPs that can de­
phosphorylate and anchor ERK, thereby increasing 
the proportion of ERK in the nucleus (Caunt et al., 
2008a; Caunt et al., 2008b; Mandl et al., 2005; 
Volmat et al., 2001). 
The data above illustrate the potential for uncoupling 
of ERK phosphorylation from nuclear localization, 
but most of the supporting evidence derives from 
studies of large cell populations (i.e. homogenates of 
cultured cells) or imaging of small numbers of cells. 
Here, we have developed a novel approach based on 
automated fluorescence microscopy to determine the 
relationship between ERK phosphorylation and 
compartmentalization in large numbers of individual 
cells. A useful feature of this approach is that it 
enables the cells to be sorted (binned) into 
subpopulations according to ppERK1/2 level. 
Plotting ppERK1/2 level (bin mean) against 
nuclear:cytoplasmic (N:C) ERK1/2 ratio then 
provides a simple measure of the relationship 
between phosphorylation and nuclear localization, 
and also enables comparison of control and 
stimulated cells under conditions of matched 
ppERK1/2 level. This analysis revealed the expected 
positive correlation between ppERK1/2 and ERK1/2 
N:C in control cells (Fig. 2B). We suspected that 
stimulation would simply extend this relationship, 
driving more cells into the higher ppERK1/2 bins 
and causing a corresponding increase in N:C 
ERK1/2. This is precisely what was seen when 
tyrosine phosphatases were inhibited with vanadate 
but the relationship between ppERK1/2 and N:C 
ERK1/2 was entirely different in cells treated with 
PDBu for 2 hr (Fig. 2B). Under this condition, 
increasing ppERK1/2 did not increase N:C ERK1/2 
and importantly, the N:C ERK1/2 ratio was greater 
in PDBu-stimulated cells than in control cells in all 
ppERK1/2 bins. Thus, 2 hours exposure to PDBu 
causes two distinct effects; firstly, it increases TEY 
phosphorylation of ERK1/2, as evidenced by the 
increase ppERK1/2 seen in analysis of the whole 
cell population (Fig. 1) and by the increased mode 
value seen in frequency distribution plots 
(supplementary Fig. 1); secondly, it causes an 
increase in N:C ERK1/2 that is not attributable to the 
increased TEY phosphorylation, because it is seen 
under conditions matched for ppERK1/2 levels (Fig. 
2B). Similar uncoupling (i.e. stimulus induced 
increases in N:C ERK1/2 with cells binned for 
indistinguishable ppERK1/2 levels) was seen at 
early time-points (5 minutes) and in 3 different cell 
types (HeLa, MCF7 and mouse embryonal 
fibroblasts) although in all cases it was less 
pronounced at 5 minutes (Fig. 2 and Supplemental 
Fig. 2). 
To our knowledge this is the first study in which 
ppERK levels and ERK compartmentalisation have 
been related in large numbers of individual adherent 
cells (data herein derive from measures of ppERK2 
and N:C ERK in several million individual cells). 
However, a key earlier study used flow cytometry to 
explore the issue of graded versus switch-like 
signalling in the ERK pathway (MacKeigan et al. 
2005). This revealed that the PDGF-stimulated 
ppERK1/2 response in Swiss 3T3 fibroblasts was 
graded, whereas c-Fos induction was an all-or­
nothing response at the individual cell level 
(MacKeigan et al. 2005). Since c-Fos induction was 
used as a readout for nuclear ERK activity it was 
suggested that graded ERK phosphorylation 
stimulated all-or-nothing nuclear localization. This 
provides another potential explanation for 
uncoupling of ppERK1/2 and N:C ERK1/2 
responses, if maximal nuclear localization occurred 
at low ppERK levels further increases in ppERK1/2 
would have no effect on nuclear localization. 
However, this appears not to be the case in our 
model as we see graded responses to PDBu for both 
ERK phosphorylation and nuclear localization (Fig. 
2). Moreover, any such relationship would be 
expected to yield a step-wise increase in binned data 
plots of ppERK1/2 against N:C ERK1/2, and no 
such increase was seen in control cells or in the 
presence of any of the stimuli used (Fig. 5). 
Interestingly, we observed graded N:C ERK1/2 and 
graded nuclear ppERK1/2 responses in HeLa and 
MCF7 cells (Fig. 2 and not shown) suggesting that 
where ERK drives switch-like down-stream 
responses (e.g. cell cycle entry and apoptosis) the 
transduction from graded to switch-like behaviour 
occurs distal to TEY phosphorylation and nuclear 
localization of ERK. 
A key finding of this study is that the relationship 
between ppERK1/2 level and N:C ERK1/2 is 
entirely different between unstimulated and PDBu­
stimulated cells (Fig. 2); namely, that PDBu has an 
effect on nuclear ERK1/2 localization beyond that 
simply attributable to TEY phosphorylation of ERK 
(Figs. 3 and 4). Since we have imaged fixed cells it 
is not possible to know whether PKC activation does 
so by altering ERK trafficking to or from the 
nucleus, or to effects on anchoring in the cytoplasm 
or nucleus. However, the uncoupling at later time 
points is most probably due to the PKC-mediated 
increase in expression of nuclear-inducible DUSPs 
(Caunt et al., 2008a; Caunt et al., 2008b). 
Nevertheless, this clearly cannot be the case for 
similar uncoupling seen in cells stimulated for only 
5 minutes with PDBu (Figs. 2C, 3, 4 and 
Supplemental Fig. 2). In confirmation of this, the 
presence of protein synthesis or tyrosine 
phosphatase inhibitors failed to have any effect on 
PDBu-mediated ERK redistribution in HeLa cells at 
these early time points, but did effect signaling in 
sustained phases (Fig. 5, (Caunt et al., 2008a; Caunt 
et al., 2008b) and not shown). Thus, we have found 
a previously unidentified component of ERK 
signaling downstream of PKC; a TEY 
phosphorylation unattributable nuclear localization 
response that does not reflect PKC-induced 
expression of nuclear anchors. Indeed, our 
observation of an acute TEY phosphorylation 
unattributable nuclear localization response is not 
readily explained bu any of the above described 
mechansisms for uncoupling of TEY 
phosphorylation from nuclear localization 
(Chuderland et al. 2008a; Chuderland et al. 2008b; 
Lorenz et al. 2009; Luttrell et al., 2001; Tohgo et al., 
2002; Caunt et al., 2008a; Caunt et al., 2008b; 
Mandl et al., 2005; Volmat et al., 2001). 
This additional component of PKC-mediated ERK 
nuclear localization was also seen using a knock­
down/add-back model in which siRNAs are used to 
reduce expression of endogenous ERK and 
recombinant adenovirus are used to express ERK2­
GFP reporters (Figs. 8 and 9). This enabled us to use 
pharmacological inhibitors to probe mechanisms in 
cells with endogenous ERK and mutated ERK2-GFP 
reporters to do so in the knock-down/add-back 
model. This revealed that the uncoupling of ERK 
phosphorylation from nuclear localization was 
prevented either by inhibition of MEK (PD184352) 
or by expression of a non-TEY phosphorylatable 
(T183/Y185A) mutant. Thus, the phosphorylation 
unattributable component of the response cannot be 
described as phosphorylation-independent. Instead, 
we show that MEK catalysed TEY phosphorylation 
of ERK is necessary, but not sufficient, for the full 
ERK nuclear localization response. 
Comparison of cells treated with PDBu, EGF and 
vanadate revealed that the ERK nuclear localization 
response is governed by stimulus rather than 
phosphorylation levels. PDBu and EGF both caused 
phosphorylation unattributable nuclear localization 
of ERK (Fig. 4). The EGF response was not affected 
by a PKC inhibitor (Ro 31-8425), indicating that this 
component of the ERK nuclear localization response 
can be induced by more than just PKC activation 
(not shown). In contrast, vanadate was unable to 
cause this component of the nuclear localization 
response, despite causing robust increases in ERK 
phosphorylation (Fig. 4). These data reveal that 
simply increasing levels of phosphorylated ERK 
does not necessarily provoke this additional 
component of the nuclear localization response. 
Accordingly, they add to the growing body of 
evidence showing that compartmentalization of ERK 
is stimulus-specific (von Kriegsheim et al., 2009; 
Whitehurst et al., 2004). 
In contrast to mutation of the TEY motif, we found 
that inhibition of catalysis (using a K52R mutation) 
or inhibition of DEF-domain binding (using a 
Y261A mutation) increased nuclear localization of 
ERK2-GFP in basal and stimulated cells. This was 
true in both average cell populations and in matched 
phosphorylation bins (Figs. 7B and 9). This could be 
because K52R ERK2-GFP is not retained in the 
cytosol, as suggested by studies showing the K52R 
mutant inhibits ERK traffic to the ruffling membrane 
but not the nucleus (Gonzalez et al., 1993; 
Yazicioglu et al., 2007). Previous studies have also 
implicated DEF-domain interactions in basal nuclear 
traffic of ERK (Casar et al., 2007), but exactly why 
K52R or Y261A mutants distinguish basal from 
stimulus-regulated ERK2-GFP localization patterns 
is currently unclear. More importantly in the context 
of this study however, we were able to establish that 
neither mutation significantly affected the 
phosphorylation unattributable component of the 
ERK nuclear localization response (Fig. 9). 
Intriguingly, we found that reduction of D-domain 
binding (using a D319N mutation) not only inhibited 
5 minutes PDBu or EGF-induced nuclear 
accumulation of ERK2-GFP (Fig. 7B and not 
shown), but also removed the phosphorylation 
unattributable component of the nuclear localization 
response (Fig. 9). Thus, PKC and EGFR both 
activate pathways causing regulation of an 
unidentified D-domain containing protein (or 
proteins) that is/are required for the full ERK 
nuclear localization response. In spite of this, the 
D319N mutation actually increased PDBu­
stimulated Egr-1-luc activity, demonstrating the 
overriding importance of D-domain containing 
phosphatases in terminating sustained ERK 
signaling (Caunt et al., 2008a; Caunt et al., 2008b; 
Mandl et al., 2005; Volmat et al., 2001). Clearly, 
more specific methods will be needed to explore this 
additional component of the localization response 
without perturbation of ERK binding to 
phosphatases and we are currently focusing on 
identifying specific D-domain containing ERK 
binding partners in this model. 
Taken together, we show that phosphorylation of 
ERK by MEK on the TEY motif is necessary but not 
sufficient for the full nuclear localization response to 
occur. Instead, there is an additional TEY 
phosphorylation unattributable component of the 
ERK translocation response that is provoked by 
PKC or EGFR activation and does not reflect 
induced expression of nuclear anchors. We also 
show that this component of the response is not 
dependent on ERK catalytic activity or DEF-domain 
association, but is reliant on binding to stimulus-
regulated D-domain containing proteins. These 
studies illustrate how spatially distinct ERK domains 
control functionally separate aspects of stimulus-
regulated subcellular targeting, and will ultimately 
inform identification of candidate binding partners 
responsible for these different modes of regulation. 
Materials and Methods 
Engineering of Plasmids and Viruses 
Viral shuttle vectors were constructed initially by 
subcloning a KpnI-NotI digest of ERK2-GFP in 
pEGFP-N1 (a gift from Prof. Louis Luttrell, Medical 
University of South Carolina, Charleston, USA) into 
a corresponding digest of pacAd5CMV K-N pA 
(donated by Prof. Beverly Davidson, University of 
Iowa, Iowa City, USA). K52R, T183/Y185A, 
Y261A and D319N mutations were introduced using 
a QuikChange PCR-based mutagenesis kit 
(Stratagene, Amsterdam, NL) and the following 
primers: 5’-CAA AGT TCG AGT TGC TAT CAG 
GAA AAT CAG TCC TTT TGA GC-3’, 5'-TGA 
TCA TAC AGG GTT CTT GGC AGA GGC TGT 
AGC CAC GCG TTG GTA C-3', 5’-AAT TTA 
AAA GCT AGA AAC GCT TTG CTT TCT CTC 
CCG CAC-3’ and 5’-GCA GTA TTA TGA CCC 
AAG TAA TGA GCC CAT TGC TGA AGC-3’ 
along with antisense primers according to 
manufacturer’s recommendations and using the 
pacAd5CMV ERK2-GFP vector as the template. Ad 
Egr-1 Luciferase and Ad CMV β-galactosidase 
reporter shuttle vectors were constructed as 
described (Caunt et al., 2008a; Armstrong et al. 
2010). Viruses were generated from shuttle vectors 
as described (Anderson et al., 2000; Caunt et al., 
2006b). Briefly, 4.5μg of shuttle vectors were 
digested alongside 1.5 μg of pacAd5 9.2-100 sub360 
backbone vector (kindly donated by Prof. Beverly 
Davidson, University of Iowa, Iowa City, USA) with 
PacI. Cut shuttle and backbone vectors were then 
mixed and transfected into low passage HEK293 
cells using Superfect (Qiagen, Crawley, UK). Cells 
were left to allow recombination between shuttle and 
backbone vectors. Verification of recombination was 
performed by restriction digest and sequence 
analysis, and Ad vectors were grown to high titre 
and purified according to standard protocols. 
Cell Culture and Transfection 
HeLa and MCF7 cells (from ECACC) were cultured 
in 10% FCS-supplemented Dulbecco’s modified 
Eagle’s medium (DMEM) without sodium pyruvate. 
Mouse embryonal fibroblasts (a kind gift from Prof 
Stephen Keyse, University of Dundee, UK) were 
cultured in 10% FCS-supplemented DMEM with 
sodium pyruvate. For 96-well plate experiments, 
cells were harvested by trypsinization and seeded at 
3-5x103 cells/well. Where necessary, cells were 
transfected using RNAiMAX reagent (Invitrogen, 
Paisley, UK) and the manufacturer’s reverse 
transfection protocol.  Cells were transfected with 2 
siRNA duplexes (Qiagen) each for ERK1: 5’-CGU 
CUA AUA UAU AAA UAU AdTdT-3’, 5’-UAU 
AUU UAU AUA UUA GAC GdGdG-3’ and 5’­
CCC UGA CCC GUC UAA UAU AdTdT-3’, 5’­
UAU AUU AGA CGG GUC AGG GdAdG-3’ and 
for ERK2: 5’-CAC UUG UCA AGA AGC GUU 
AdTdT-3’, 5’-UAA CGC UUC UUG ACA AGU 
GdTdT-3’ and 5’-CAU GGU AGU CAC UAA CAU 
AdTdT-3’, 5’-UAU GUU AGU GAC UAC CAU 
GdAdT-3’ which have been validated in recent 
publications (Caunt et al., 2008a; Caunt et al., 
2008b; Dimitri et al., 2005). A mixture of all 4 
ERK1/2 duplexes or control siRNA against GFP 
(Ambion, Warrington, UK) was used in experiments 
at 2.5 nM total concentrations. Sixteen hours after 
siRNA transfection, cells were transduced with 0 or 
1.5x106 plaque-forming units (pfu)/ml Ad WT, 
K52R, T183/Y185A, Y261A or D319N ERK2-GFP 
vector in DMEM with 10% FCS. The Ad-containing 
medium was removed after 4–6 hours and replaced 
with fresh DMEM supplemented with 0.1% FCS. 
The cells were then maintained for 16–24 h in 
culture prior to stimulation with GnRH EGF 
(Calbiochem, San Diego, CA, USA), PDBu (phorbol 
12, 13-dibutyrate, Sigma) or sodium orthovanadate 
(Sigma).  In some experiments, cells were treated 
with 10 μM PD184352 (Enzo Life Sciences, Exeter, 
UK), 200 nM Ro31-8425 (Roche, Welyn Garden 
City, UK) 30μM cycloheximide (Sigma) or 1mM 
sodium orthovanadate (Sigma) for 10 min prior to 
stimulation.  Expression levels of GFP-tagged 
fusions were compared using western blotting 
techniques (see Fig. 6A) as well as comparison of 
mean cell fluorescence in microscopy assays. 
Western Blotting 
HeLa cells were plated in 6-well plates at 2.5x105 
cells/well. Where required, cells were transfected 
with 2.5 nM ERK1/2 siRNAs prior to Ad 
transduction as above. Following treatment noted in 
figure legends, cells were lysed as described, prior to 
western blotting. Total and ppERK1/2 were detected 
using rabbit anti-ERK1/2 monoclonal (clone 137F5, 
1:1000; Cell Signaling Technology, Hitchin, UK) 
and mouse anti-ppERK1/2 monoclonal antibody 
(clone MAPK-YT, 1:2000, Sigma), respectively. 
Total and Ser217/221 phosphorylated MEK1/2 were 
detected using rabbit anti-MEK1/2 monoclonal 
(clone 47E6, 1:1000, Cell Signaling Technology) 
and rabbit anti-ppMEK1/2 monoclonal (clone 41G9, 
1:1000, Cell Signaling Technology), respectively. 
DUSP1 was detected using rabbit anti-DUSP1 
polyclonal (M-18, 1:500, Santa Cruz Biotechnology, 
CA USA). Antibodies were visualized using 
horseradish peroxidase linked secondary antibody 
and enhanced chemiluminescence kit (GE 
Healthcare, Amersham, UK). 
High-content Image Acquisition and Analysis 
Cells were plated (and transfected with siRNA, and 
Ad vectors as necessary) as described above on 
Costar plain black-wall 96-well plates (Corning, 
Arlington, UK) prior to treatment as noted in figure 
legends. Cells were fixed in 4% 
paraformaldehyde/PBS and permeabilized in -20˚C 
methanol. After blocking in 5% normal goat 
serum/PBS, cells were probed with mouse anti­
ppERK1/2 monoclonal antibody (clone MAPK-YT, 
1:200, Sigma) and rabbit anti-ERK1/2 monoclonal 
(clone 137F5, 1:100, Cell Signaling Technology) in 
PBS. Alexa 488-conjugated goat anti-mouse and 
Alexa 546-conjugated goat anti-rabbit secondary 
antibodies (1:200, Invitrogen) and DAPI/PBS 
(600nM) were used to visualize ppERK1/2, ERK1/2 
antibodies and stain nuclei, respectively in imaging 
of endogenous kinases. For imaging cells transduced 
with Ad ERK2-GFP, cells were counterstained with 
rabbit anti-ERK1/2 monoclonal (1:100) and Alexa 
546-conjugated goat anti-rabbit secondary (1:200) 
for assessing expression levels and setting filter 
levels (to ensure only ERK2-GFP expressing cells 
within physiological ranges were included in 
analysis in subsequent assays). For imaging ppERK2 
in cells expressing ERK2-GFP, cells were 
counterstained with mouse anti ppERK1/2 
monoclonal (1:200) and Alexa 546-conjugated goat 
anti mouse secondary (1:200) as above. Image 
acquisition in each well was performed on an IN 
Cell Analyzer 1000 (GE Healthcare) microscope, 
using a x10 objective and 360nm (DAPI), 475nm 
(Alexa 488 and GFP) and 535nm (Alexa 546) 
excitation filters, and monitored through 460nm, 
535nm and 620nm emission filters, respectively, 
with a 61002 trichroic mirror (GE Healthcare). 
Analysis of endogenous ERK1/2 and ppERK1/2 was 
performed using the Multi-target Analysis algorithm 
and “region growing” cell identification module in 
the IN Cell Analyzer Workstation (GE Healthcare) 
using DAPI and ERK1/2 stained images to define 
nuclear and cytoplasmic regions, respectively, which 
were used as a mask for detection of changes in 
ppERK1/2 staining. ERK2-GFP and ERK1/2 or 
ppERK1/2 stained cells were similarly analysed 
using the Multi-target Analysis algorithm, but using 
the more sensitive “multiscale top hat” cell 
identification module (IN Cell Analyzer 
Workstation, GE Healthcare). In both ppERK2 and 
GFP readouts, cells expressing sub- or super-
physiological levels of ERK2-GFP were excluded 
from analysis (based on comparisons of frequency 
histograms of ERK1/2 staining intensity in cells 
transfected with Ctrl siRNA, ERK1/2 siRNAs and 
with ERK1/2 siRNAs plus Ad ERK2-GFP). Mitotic 
and apoptotic nuclei were excluded from analysis, as 
were aberrantly identified cells using a “decision 
tree” filter based on multiple readouts of intensity 
and shape defined in nuclear and cellular regions. 
Imaging data are reported as ppERK1/2 intensity 
(mean fluorescence intensity per cell) or as a ratio of 
nuclear to cytoplasmic stain intensity (N:C ratio). 
Sorting of cells into linked subpopulations according 
to ppERK1/2 staining intensity was performed using 
a macro in Microsoft Excel (kindly designed by Neil 
Rich, University of Bristol, UK). 
Luciferase Assays 
Cells were transfected with siRNA, transduced with 
Ad vectors and plated as described above on Costar 
plain black-wall 96-well plates (Corning), but 
including Ad Egr-1 Luciferase and Ad CMV β­
galactosidase reporter vectors. Following treatment 
with PDBu, cells were washed in ice-cold PBS, 
lysed and assessed for luciferase activity by 
chemical luminescence following the addition of 
luciferin substrate (Promega, Southampton, UK). β­
galactosidase activity was used to correct luciferase 
activity for transfection efficiency, as measured 
following the addition of chlorophenol red-β-D­
galactopyranoside substrate (Roche). 
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Figure Legends 
Figure 1 Spatiotemporal characteristics of PDBu-stimulated ERK regulation in cell populations. 
HeLa cells were seeded in 96-well imaging plates and kept in reduced (0.1%) serum for 16 hours prior to 
addition of 1 μM PDBu as indicated. (A) Cells were fixed and stained for endogenous ppERK1/2, ERK1/2 
and DAPI before image acquisition and analysis (as described in Materials and Methods). Representative 
images of single fields of cells (left panels) and magnified areas of fields to show changes in subcellular 
localization (right panels) are shown. Outlines denote the segmentation of cells according to DAPI and 
ERK1/2 staining using IN Cell Analyzer software for the calculation of whole-cell ppERK1/2 intensity and 
N:C ERK1/2 ratio shown in (B). (B) Nine images per well, per fluorophore were acquired from cells in 
duplicate wells after PDBu treatment as indicated. Graphs represent population average values for ppERK1/2 
intensity (left panel) and ERK1/2 N:C ratio (right panel) derived from 4 separate experiments (approx. 
15,000-18,000 individual cells per condition) ±SEM. (C) Whole cell lysates of HeLa cells treated with PDBu 
were immunoblotted for phospho Ser217/221 MEK1/2 (ppMEK1/2), phospho Thr183/Tyr185 ERK1/2 
(ppERK1/2), ERK1/2 and DUSP1 as indicated. 
Figure 2 Uncoupling of ERK phosphorylation from nuclear localization. 
(A) HeLa cells were seeded in 96-well imaging plates and kept in reduced (0.1%) serum for 16 hours prior to 
addition of 0 (Ctrl), 0.1 or 1 μM PDBu for 5 minutes as indicated. Cells were fixed and stained for 
ppERK1/2, ERK1/2 and DAPI before image acquisition and analysis (as described in Fig. 1). Frequency 
histograms of individual cells were plotted (pooled from 2 independent experiments) according to ppERK1/2 
staining intensity (top panel) and ERK1/2 N:C ratio (bottom panel) from the same cell population in both 
graphs. (B) Cells were treated with 1 μM PDBu for 0 (Ctrl), 5 or 120 minutes as indicated before fixation, 
imaging and analysis as described in Fig. 1. In order to directly compare ppERK1/2 levels to ERK1/2 N:C, 
individual cells were sorted into bins of ppERK1/2 staining intensity (80 AFU per bin, using a minimum bin 
size of 50 cells per experiment). The average ERK1/2 N:C ratio within each defined bin of ppERK1/2 
staining intensity was calculated and is shown plotted against average ppERK1/2 stain intensity. Data are 
shown from 6 separate experiments ±SEM. Note that this plot effectively obscures the effect of the stimulus 
on ERK phosphorylation because the major effect of PDBu is to increase the number of cells in the higher 
ppERK1/2 bins (and this is not evident in the figure). In doing so it reveals the TEY phosphorylation 
unattributable effect of PDBu: that is, the increase in ERK1/2 N:C under conditions matched for 
indistinguishable ppERK1/2 levels. 
Figure 3 ERK nuclear localization is proportional to stimulus but not phosphorylation levels.

HeLa cells were seeded in 96-well imaging plates and kept in reduced (0.1%) serum for 16 hours prior to

addition of increasing concentrations of PDBu as indicated for 5 minutes. Cells were fixed and stained for

ppERK1/2, ERK1/2 and DAPI before image acquisition and analysis (as described in Fig. 1). (Top panel) 

The graph represents population average values for ppERK1/2 intensity (right y-axis) and ERK1/2 N:C ratio

(left y-axis). (Bottom panel) This plot shows the same time-course as in (A), comparing ERK1/2 N:C ratio

(left y-axis) only cells within a comparable range (240-320 AFU) of ppERK1/2 staining intensity (right y-

axis). Data are shown from 6 separate experiments ±SEM. **= p<0.01, comparing control and PDBu­

stimulated conditions for each readout, according to one-way ANOVA and Dunnet’s post-hoc test.

Figure 4 Stimulus-induced changes in ERK localization occur at matched levels of phosphorylation.

HeLa cells were seeded in 96-well imaging plates and kept in reduced (0.1%) serum for 16 hours prior to

addition of 1 μM PDBu for the times indicated. Cells were fixed and stained for ppERK1/2, ERK1/2 and

DAPI before image acquisition and analysis (as described in Fig. 1). (A) The graph represents population

average values for ppERK1/2 intensity (right y-axis) and ERK1/2 N:C ratio (left y-axis) derived from 3

separate experiments ±SEM. (B) This plot shows the same time-course as in (A), comparing ERK1/2 N:C

ratio (left y-axis) only cells within a comparable range (240-320 AFU) of ppERK1/2 staining intensity (right

y-axis). Data are shown from 3 separate experiments ±SEM.

Figure 5 The relationship between ERK phosphorylation and nuclear localization is stimulus specific.

HeLa cells were seeded in 96-well imaging plates and kept in reduced (0.1%) serum for 16 hours prior to

addition of 1 μM PDBu, 10 nM EGF or 1 mM sodium orthovanadate (vanadate) for the times indicated.

Cells were fixed and stained for ppERK1/2, ERK1/2 and DAPI before image acquisition and analysis (as

described in Fig. 1). (A) The graph represents population average values for ppERK1/2 intensity (right y-
axis) and ERK1/2 N:C ratio (left y-axis) derived from 3 separate experiments ±SEM. (B) The plots represent 
the average ERK1/2 N:C ratio in cell populations stimulated with vehicle (Ctrl) or stimulated for 5 minutes 
(EGF and PDBu) or 3 hours (vanadate) within defined bins of ppERK1/2 staining intensity (80 AFU per bin, 
accepting a minimum of 50 cells per bin in each experiment). Data are shown from 3 separate experiments 
±SEM. 
Figure 6 Uncoupling of ERK phosphorylation from nuclear localization requires MEK activity. 
HeLa cells were seeded in 96-well imaging plates and kept in reduced (0.1%) serum for 16 hours prior to 
addition of vehicle (Ctrl) 200 nM Ro31-8425 PKC inhibitor, 10 μM PD184352 MEK inhibitor, 200 nM 
SU6656 Src inhibitor, 1 mM sodium orthovanadate (vanadate) tyrosine phosphatase inhibitor or 30 μM 
cycloheximide (CHX) protein synthesis inhibitor for 10 minutes as indicated. Cells were then treated with 0­
10 μM PDBu for 5 minutes prior to fixation and staining for ppERK1/2, ERK1/2 and DAPI before image 
acquisition and analysis (as described in Fig. 1). (A) The histograms show population average values for 
ppERK1/2 and ERK1/2 N:C after treatment with inhibitors and either vehicle (Ctrl) or 1 μM PDBu as 
indicated. Data are shown from 3 separate experiments ±SEM. **= p<0.01, comparing Ctrl and PDBu­
stimulated conditions with inhibitor co-incubations for each readout, according to one-way ANOVA and 
Dunnet’s post-hoc test. (B) The graphs represent full dose-response curves of ERK1/2 N:C ratio after 
treatment, comparing only cells within a comparable range (240-320 AFU) of ppERK1/2 staining intensity. 
Data are shown from 3 separate experiments ±SEM. **= p<0.01, comparing Ctrl and inhibitor-treated curves 
using two-way ANOVA and Bonferroni post-hoc tests 
Figure 7 Phosphorylation, catalysis and docking domains influence ERK2-GFP localization and signaling. 
(A) HeLa cells transfected with control siRNAs (Ctrl) or ERK1/2 siRNAs were transduced with Ad wild-
type (WT), K52R, T183/Y185A, Y261A or D319N-mutated ERK2-GFP as indicated and stimulation with 
vehicle (-) or 1 μM PDBu (+) for 5 minutes before lysis. ERK1/2, MEK1/2 and ppMEK1/2 were assessed by 
immunoblotting of whole cell lysates as indicated. Densitometry (n=3) reveals >95% knock-down of 
ERK1/2 in control and PDBu stimulated cells in all Ad ERK2-GFP conditions with no significant effect on 
MEK expression or phosphorylation. (B) Cells transfected and transduced as described in (A) were 
stimulated for 5 minutes with indicated concentrations of PDBu before fixation, ppERK2 staining, image 
acquisition and analysis as described in Materials and Methods to assess whole-cell levels of ppERK2-GFP 
phosphorylation (ppERK2, top panel) and nucleo-cytoplasmic distribution of ERK2-GFP (ERK2-GFP N:C, 
middle panel). For Egr-1 luciferase assays, Ad Egr-1 luciferase and Ad CMV β-galactosidase vectors were 
also added to cells before stimulation with PDBu for 6h and assay of luciferase activity (Egr-1 Luc), and are 
expressed as fold induction (bottom panel). Data are shown from 3 separate experiments ±SEM. *= p<0.05 
and **= p<0.01, comparing WT to mutant conditions, according to two-way ANOVA and Bonferroni post-
hoc tests. 
Figure 8 Uncoupling of endogenous ERK phosphorylation from nuclear localization is replicated in ERK2­
GFP expressing cells. 
Non-transfected HeLa cells (left panel), and HeLa cells transfected with ERK1/2 siRNAs and transduced 
with Ad WT ERK2-GFP (right panel) were treated with vehicle (Ctrl), 0.1 or 1 μM PDBu for 5 minutes prior 
to staining, imaging and analysis as described in Materials and Methods. The plots show comparison of 
average ERK1/2 N:C ratio in cell populations within defined bins of ppERK1/2 staining intensity (80 AFU 
per bin, accepting a minimum of 50 cells per bin in each experiment). Data are shown from 3 separate 
experiments ±SEM. 
Figure 9 D319N mutation of ERK2-GFP inhibits stimulus-induced nuclear localization that is not 
attributable to increases in TEY phosphorylation. 
(A) HeLa cells transfected with ERK1/2 siRNAs were transduced with Ad wild-type (WT), K52R, Y261A or 
D319N-mutated ERK2-GFP as indicated and stimulation with vehicle (Ctrl), 0.1 or 1 μM PDBu for 5 
minutes prior to staining for ppERK2 and DAPI. Imaging and analysis was carried out as described in 
Materials and Methods. The plots show comparison of average ERK1/2 N:C ratio in cell populations within 
defined bins of ppERK1/2 staining intensity (80 AFU per bin, accepting a minimum of 50 cells per bin in 
each experiment). Data are shown from 3 separate experiments ±SEM. (B) The graphs show a full dose-
response curves of ERK2-GFP N:C ratio (bottom panel) for cells transfected and transduced as described in 
(A) and stimulated for 5 minutes with PDBu, comparing only cells within a comparable range (160-240 
AFU) of ppERK1/2 staining intensity (top panel). Data are shown from 3 separate experiments ±SEM. *= 
p<0.05 and **= p<0.01, comparing WT to mutant conditions, according to two-way ANOVA and 
Bonferroni post-hoc tests. 
Supplementary Figure 1 Time-course of stimulus-induced uncoupling of ERK phosphorylation from 
nuclear localization. 
HeLa cells were seeded in 96-well imaging plates and kept in reduced (0.1%) serum for 16 hours prior to 
addition of 1 μM PDBu as indicated for 5-360 minutes. Cells were fixed and stained for ppERK1/2, ERK1/2 
and DAPI before image acquisition and analysis (as described in Fig. 1). Cell populations pooled from 3 
independent experiments were sorted into frequency histograms of ppERK1/2 staining intensity (left panels) 
and ERK1/2 N:C ratio (middle panels). To compare ppERK1/2 to ERK1/2 N:C ratio, cells were sorted into 
cell subpopulations (bins) of defined ppERK1/2 staining intensity (80 AFU per bin), before calculating the 
average ERK1/2 N:C value within each bin  (using a minimum of 50 cells per bin, as described in Fig. 2B). 
The graphs are plotted as average ERK1/2 ratio against ppERK1/2 staining intensity within each 80 AFU 
bin. Data are shown from 3 separate experiments ±SEM 
Supplementary Figure 2 Stimulus-induced uncoupling of ERK phosphorylation from nuclear localization 
in MCF7 and primary mouse embryo fibroblast cells. 
MCF7 cells (A-D) and primary mouse embryo fibroblasts (E-H) were seeded in 96-well imaging plates and 
kept in reduced (0.1%) serum for 16 hours prior to addition of 1 μM PDBu as indicated for 5-360 minutes. 
Cells were fixed and stained for ppERK1/2, ERK1/2 and DAPI before image acquisition and analysis (as 
described in Fig. 1). (A and E) Graphs represent population average values for ppERK1/2 intensity and 
ERK1/2 N:C ratio derived from 6 separate experiments ±SEM. (B, D, F and H) Cell populations pooled 
from 3 independent experiments were sorted into frequency histograms of ppERK1/2 staining intensity (B 
and F) and ERK1/2 N:C ratio (C and G). (D and H) Cells were imaged and analysed as described in (A and 
D) after stimulation for 0, 5, 120 or 360 minutes with 1μM PDBu (as indicated). To compare ppERK1/2 to 
ERK1/2 N:C ratio, cells were sorted into cell subpopulations of defined (40-80 AFU) ppERK1/2 staining 
intensity, before calculating the average ERK1/2 N:C value within each subpopulation (or “bin”, as 
described in Fig. 2B). The graphs are plotted as average ppERK1/2 stain intensity within each 40-80 AFU 
bin against the average N:C ERK ratio for that bin. Data are shown ± SEM of individual cells with each bin 
containing data from >50 cells. 
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